Annual Total Liabilities
$3.72 M
+$1.97 M+112.88%
31 December 2023
Summary:
Immix Biopharma annual total liabilities is currently $3.72 million, with the most recent change of +$1.97 million (+112.88%) on 31 December 2023. During the last 3 years, it has fallen by -$1.55 million (-29.38%). IMMX annual total liabilities is now -29.38% below its all-time high of $5.27 million, reached on 31 December 2020.IMMX Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Total Liabilities
$7.59 M
+$2.65 M+53.51%
30 September 2024
Summary:
Immix Biopharma quarterly total liabilities is currently $7.59 million, with the most recent change of +$2.65 million (+53.51%) on 30 September 2024. Over the past year, it has increased by +$4.77 million (+168.65%). IMMX quarterly total liabilities is now at all-time high.IMMX Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
IMMX Total Liabilities Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +112.9% | +168.7% |
| 3 y3 years | -29.4% | +13.4% |
| 5 y5 years | - | - |
IMMX Total Liabilities High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -29.4% | +1742.5% | at high | +3657.8% |
| 5 y | 5 years | -29.4% | +1742.5% | at high | +3657.8% |
| alltime | all time | -29.4% | +1742.5% | at high | +3657.8% |
Immix Biopharma Total Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $7.59 M(+53.5%) |
| June 2024 | - | $4.94 M(-26.4%) |
| Mar 2024 | - | $6.72 M(+80.4%) |
| Dec 2023 | $3.72 M(+112.9%) | $3.72 M(+31.7%) |
| Sept 2023 | - | $2.83 M(+17.9%) |
| June 2023 | - | $2.40 M(+62.7%) |
| Mar 2023 | - | $1.47 M(-15.8%) |
| Dec 2022 | $1.75 M | $1.75 M(+170.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2022 | - | $646.50 K(-33.8%) |
| June 2022 | - | $977.20 K(+167.7%) |
| Mar 2022 | - | $365.10 K(+80.7%) |
| Dec 2021 | $202.00 K(-96.2%) | $202.00 K(-97.0%) |
| Sept 2021 | - | $6.69 M(+7.9%) |
| June 2021 | - | $6.20 M(+17.7%) |
| Dec 2020 | $5.27 M(+14.8%) | $5.27 M |
| Dec 2019 | $4.59 M | - |
FAQ
- What is Immix Biopharma annual total liabilities?
- What is the all time high annual total liabilities for Immix Biopharma?
- What is Immix Biopharma annual total liabilities year-on-year change?
- What is Immix Biopharma quarterly total liabilities?
- What is the all time high quarterly total liabilities for Immix Biopharma?
- What is Immix Biopharma quarterly total liabilities year-on-year change?
What is Immix Biopharma annual total liabilities?
The current annual total liabilities of IMMX is $3.72 M
What is the all time high annual total liabilities for Immix Biopharma?
Immix Biopharma all-time high annual total liabilities is $5.27 M
What is Immix Biopharma annual total liabilities year-on-year change?
Over the past year, IMMX annual total liabilities has changed by +$1.97 M (+112.88%)
What is Immix Biopharma quarterly total liabilities?
The current quarterly total liabilities of IMMX is $7.59 M
What is the all time high quarterly total liabilities for Immix Biopharma?
Immix Biopharma all-time high quarterly total liabilities is $7.59 M
What is Immix Biopharma quarterly total liabilities year-on-year change?
Over the past year, IMMX quarterly total liabilities has changed by +$4.77 M (+168.65%)